Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
C2 is a specific experimental intervention arm used in a clinical trial conducted by Southern Illinois University Carbondale to investigate the effects of caffeine and hydration on vocal performance. The intervention consists of a 200 mg oral dose of caffeine, administered as a tablet, taken with 500 mL (0.5 liters) of water. The study aims to determine if systemic hydration can mitigate the potentially dehydrating or performance-degrading effects of caffeine on the vocal folds and voice quality in healthy adults. Caffeine acts primarily as a non-selective antagonist of adenosine receptors, which leads to central nervous system stimulation and potential peripheral effects on fluid balance and smooth muscle function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on caffeine + water.